Brookline Capital Management dropped their FY2029 EPS estimates for Caribou Biosciences in a report released on Tuesday, March 11th. Brookline Capital Management analyst L. Cann now forecasts that the ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback